project id: TCGA-BRCA; case submitter id: TCGA-A1-A0SG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 9.5; spectrophotometer method: UV Spec; age at index: 61; days to birth: -22380; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1945; age at diagnosis: 22380; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 434.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8507/3; primary diagnosis: Intraductal micropapillary carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 120.0; sample id: 6bfd7e43-77e4-4666-9b28-c5d4cdcd6ad7; sample submitter id: TCGA-A1-A0SG-01A; portion id: 05ae559d-453d-4a72-bba2-2360b151ccfd; portion submitter id: TCGA-A1-A0SG-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0;